Skip to main content
. 2022 May 27;15(6):677. doi: 10.3390/ph15060677

Figure 1.

Figure 1

Distribution of impaired glucose metabolism events. Percentages of reporting impaired glucose metabolism events for groups (“diabetes in pregnancy”, “acute complications of diabetes”, “pre-diabetes”, “type 1 diabetes mellitus”, “type 2 diabetes mellitus”, “high glucose levels”, “diabetes mellitus inadequate control”, “diabetes mellitus not specified”, and “hypoglycaemia”) and type of COVID-19 vaccine (Pfizer-BioNTech, Moderna, Oxford–AstraZeneca, and Janssen vaccines) reported in Eudravigilance from 1 January 2021 to 11 December 2021.